Number of included patients WARD Medical RCT (n=300) 100% WARD Surgery RCT (n=400) 100% WARD Surgery RCT II (n=504) 78% WARD Home II (n=120) 71% WARD Prospective study (n=3095) 17% WARD glucose validation (N=60) 98% WARD Glucose RCT (N=200) 37% WARD Fase 1 (N=100) 7% [Updated 11-03-2024]